William Brad Parker MD
Orthopedic Sports Medicine
Clinical Professor, Obstetrics & Gynecology, David Geffen School of Medicine at UCLA
Join to View Full Profile
1301 W 38th St 102Austin, TX 78705
Phone+1 512-454-4561
Fax+1 512-467-2906
Dr. Parker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterResidency, Orthopaedic Surgery, 1987 - 1991
University of Texas Southwestern Medical CenterInternship, Orthopaedic Surgery, 1986 - 1987
University of Texas Southwestern Medical SchoolClass of 1986
Certifications & Licensure
TX State Medical License 1987 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Publications & Presentations
PubMed
- 9 citationsIntratumoral generation of 2-fluoroadenine to treat solid malignancies of the head and neck.Turang E. Behbahani, Eben L. Rosenthal, William B. Parker, Eric J. Sorscher
Head & Neck. 2019-06-01 - 52 citationsNovel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4′-thio-2′-deoxycytidine and 5-aza-4′-thio-2′-deoxycytidineJaideep V. Thottassery, Vijaya Sambandam, Paula W. Allan, Joseph A. Maddry, Yulia Maxuitenko
Cancer Chemotherapy and Pharmacology. 2014-06-08 - 25 citationsA prescription for clinical immunology: the pills are available and ready for testing. A review.William Parker, Sarah E. Perkins, Matthew Harker, Michael P. Muehlenbein
Current Medical Research and Opinion. 2012-05-21
Grant Support
- 2011 Nucleosides, Nucleotides, And Oligonucleotides GrcNational Cancer Institute2011
- Purine Analog Anti-Mycobacterial Drug DevelopmentNational Institute Of Allergy And Infectious Diseases2005–2009
- Development Of New Antitumor AgentsNational Cancer Institute2004–2005
- Tumor Sensitization To Purine Analogs By E.Coli PNPNational Cancer Institute2000–2004
- Mechanism Of Action Of Nucleoside AnalogsNational Cancer Institute2001–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
